超声造影在CT和MRI发现的肝脏病灶影像学分类中的作用
这项多中心回顾性分析纳入1264例高危HCC参与者,先做CT/MRI再做超声造影并按LI-RADS分类,评估三种阶梯诊断策略。策略3对CT/MRI LR-3/4病灶加做超声造影,敏感度88.8% vs 79.9%(P<0.001),特异度88.2% vs 91.3%(P>0.05),活检率31.5%降至22.4%(P=0.028),假阴性率20.1%降至11.2%(P<0.001)。
要点
- 对CT/MRI判为LR-3或LR-4的病灶加做超声造影,可提高HCC诊断敏感度并减少活检。
- 策略3敏感度88.8% vs CT/MRI LI-RADS单独79.9%,特异度88.2% vs 91.3%,差异无统计学意义。
- 96%(55/57)的CT/MRI LR-3和97%(77/79)的CT/MRI LR-4病灶经超声造影辅助被准确诊断并按HCC治疗。
核心结论
- 先CT/MRI、对LR-3/4病灶再加做超声造影的阶梯式方法可提高HCC诊断效能并优化临床决策。
研究设计与样本
- 多中心回顾性分析,前瞻性招募的高危HCC参与者来自4家机构,2017年1月至2021年12月,共1264例,先CT/MRI后超声造影,按CT/MRI/CEUS LI-RADS分类,以病理或超过1年随访为标准。
诊断标准与关键数值
- 策略3对CT/MRI LR-3/4病灶加做超声造影:敏感度88.8% vs CT/MRI LI-RADS单独79.9%(P<0.001),特异度88.2% vs 91.3%(P>0.05)。
临床应用与阅片要点
- 对CT/MRI判为LR-3或LR-4的病灶加做超声造影,可使活检率由31.5%降至22.4%(P=0.028),假阴性率由20.1%降至11.2%(P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND & AIMS: Timely and accurate diagnosis of hepatocellular carcinoma (HCC) is essential for improving patient outcomes and guiding treatment. This multicenter study aimed to optimize the diagnostic workflow for HCC through a step-wise combination of CT/MRI and contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS).
METHODS: This was a multicenter, retrospective analysis of prospectively recruited high-risk HCC participants with liver observations from 4 institutions, between January 2017 and December 2021. These participants initially underwent CT/MRI followed by CEUS, with observations categorized according to CT/MRI/CEUS LI-RADS. Three step-wise diagnostic strategies were evaluated, starting with CT/MRI and followed by CEUS, and compared to CT/MRI LI-RADS alone. Performance metrics included AUC, accuracy, sensitivity, specificity, PPV, and NPV, using pathology or over one year of follow-up as standards. The impact on clinical decisions was measured by false-negative, false-positive, and biopsy rates.
RESULTS: Of 1264 participants, 874 (69%) were confirmed as HCC. The step-wise strategies outperformed CT/MRI LI-RADS. Strategy-3, which involved subsequent CEUS for CT/MRI LR-3/4 observations, significantly improved sensitivity (88.8% vs. 79.9%, P < 0.001) while maintaining comparable specificity (88.2% vs. 91.3%, P > 0.05). Strategy-3 reduced biopsy rate (31.5-22.4%, P = 0.028) and decreased false-negative rate (20.1-11.2%, P < 0.001). Additionally, 96% (55/57) of CT/MRI LR-3 and 97% (77/79) of CT/MRI LR-4 observations were accurately diagnosed and treated as HCC, with 61% (74/121) of CT/MRI LR-4 observations avoiding biopsy with CEUS-assisted.
CONCLUSION: A step-wise approach using CT/MRI followed by CEUS for LR-3/4 observations improved the diagnostic performance and further refined clinical decision-making in HCC.
TRIAL REGISTRATION: Clinical Trial Registration Number: ChiCTR-DDD-16010089.
引用
- Huang H, He DN, Lu RF, et al. The role of contrast-enhanced ultrasound in the radiological classification of liver observations identified by CT and MRI. Radiol Med. 2025. PMID: 40126795. doi:10.1007/s11547-025-01995-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。